Table 13Sensitivity Analysis Varying Adherence to Screening*

StrategyColposcopiesIncremental ColposcopiesLife Years (LYs)Incremental LYsICLY
No intervention069016.30
Age 25, q520720769120.83104.532
Age 20, q5212569122.391.563
Age 25, q333111969156.8434.453
Age 24, q247314269183.1826.345
Age 20, q24942169185.652.479
Age 25, q185135769217.9332.2811
Age 24, q18671669218.920.9916
Age 23, q18841769219.860.9418
Age 19, q19244069222.012.1519
Age 18, q1928469222.190.1822
Age 17, q1931369222.280.0933
Age 16, q1935469222.320.04100
Age 15, q1939469222.32<0.01627
*

Results are presented as expected colposcopies per 1,000 women, incremental colposcopies, life-years , incremental life-years, and incremental colposcopies per life-year (ICLY) associated with screening beginning at different ages (varying in 1-year increments from age 15 to 25 years). Screening intervals of 1 (q1), 2 (q2), 3 (q3), and 5 years (q5) are compared.

From: Results

Cover of Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force
Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force [Internet].
Evidence Syntheses, No. 86s.
Kulasingam SL, Havrilesky L, Ghebre R, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.